Large animal normal tissue tolerance with boron neutron capture.
OBJECTIVE
Normal tissue tolerance of boron neutron capture irradiation using borocaptate sodium (NA2B12H11SH) in an epithermal neutron beam was studied.


METHODS
Large retriever-type dogs were used and the irradiations were performed by single dose, 5 x 10 dorsal portal. Fourteen dogs were irradiated with the epithermal neutron beam alone and 35 dogs were irradiated following intravenous administration of borocaptate sodium.


RESULTS
Total body irradiation effect could be seen from the decreased leukocytes and platelets following irradiation. Most values returned to normal within 40 days postirradiation. Severe dermal necrosis occurred in animals given 15 Gy epithermal neutrons alone and in animals irradiated to a total peak physical dose greater than 64 Gy in animals following borocaptate sodium infusion. Lethal brain necrosis was seen in animals receiving between 27 and 39 Gy. Lethal brain necrosis occurred at 22-36 weeks postirradiation. A total peak physical dose of approximately 27 Gy and blood-boron concentrations of 25-50 ppm resulted in abnormal magnetic resonance imaging results in 6 months postexamination. Seven of eight of these animals remained normal and the lesions were not detected at the 12-month postirradiation examination.


CONCLUSIONS
The bimodal therapy presents a complex challenge in attempting to achieve dose response assays. The resultant total radiation dose is a composite of low and high LET components. The short track length of the boron fission fragments and the geometric effect of the vessels causes much of the intravascular dose to miss the presumed critical target of the endothelial cells. The results indicate a large dose-sparing effect from the boron capture reactions within the blood.
Gavin
P R
PR
Department of Veterinary Clinical Sciences, Washington State University, Pullman 99164-6610.
Kraft
S L
SL
DeHaan
C E
CE
Swartz
C D
CD
Griebenow
M L
ML
D000818:Animals; D001894:Borohydrides / Q000627:therapeutic use; D016754:Boron Neutron Capture Therapy; D001921:Brain / Q000528:radiation effects; D004285:Dogs; D004307:Dose-Response Relationship, Radiation; D011836:Radiation Tolerance; D012867:Skin / Q000528:radiation effects; D013438:Sulfhydryl Compounds / Q000627:therapeutic use
D001894:Borohydrides; D013438:Sulfhydryl Compounds; C014651:mercaptoundecahydrododecaborate